Side-by-side comparison of AI visibility scores, market position, and capabilities
Alto Pharmacy is a full-service digital pharmacy delivering prescriptions to patients with a tech-enabled experience that coordinates with providers and insurance.
Alto Pharmacy is a digital pharmacy company founded in 2015 that provides a tech-enabled prescription delivery experience for patients managing ongoing medications and specialty drugs. The company differentiates from traditional pharmacies through proactive care coordination, where pharmacy staff work with patients and prescribers to address insurance prior authorizations, copay assistance programs, and adherence support rather than requiring patients to navigate these barriers themselves. Alto serves both retail pharmacy customers and specialty pharmacy customers managing complex medications for conditions including fertility, oncology, HIV, and mental health. The company raised over $350M and delivers to patients in multiple major US metropolitan areas. Alto's platform integrates with electronic health record systems to receive prescriptions digitally and provides prescribers with real-time visibility into whether patients have filled their medications. The company has positioned its proactive, high-touch model as particularly valuable for specialty drugs where adherence, insurance navigation, and side effect management require more support than standard retail pharmacies provide. Alto Pharmacy serves as an alternative to incumbent pharmacy benefit managers for employers and health plans that want better specialty pharmacy management.
Raised $900M Series E at $11B valuation (Oct 2025). CEO projects ~$2B in 2026 sales. Launched women's health LLM (Feb 2026). Team USA LA28 Olympic partner.
Oura is the maker of the Oura Ring, a premium smart ring that tracks sleep, recovery, readiness, and health metrics through continuous biometric sensing. The company raised $900 million in Series E financing at an $11 billion valuation in October 2025, reflecting the doubling of its revenue to $500 million in 2024 and a projected $1.5–2 billion in 2026 sales as it expands global distribution into India, UAE, and Latin America.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.